Idiopathic orbital disease and corticosteroids as first-line treatment: literature review
https://doi.org/10.26295/OS.2020.64.89.013
Abstract
Orbital inflammation may occur as local manifestation of systemic disease, in infections, neoplasms and as idiopathic process. Development of new therapeutic modalities requires more fundamental comprehension of the disease and collaboration with other medical specialists, especially rheumatologists and transplantologists.
About the Authors
I. A. Levashov
ФГАУ НМИЦ «МНТК «Микрохирургия глаза» им. акад. С. Н. Федорова
Россия
Россия
A. A. Yarovoy
ФГАУ НМИЦ «МНТК «Микрохирургия глаза» им. акад. С. Н. Федорова
Россия
Россия
References
1. Yuen S. J. A., Rubin P. A. D. Idiopathic Orbital Inflammation. Distribution, Clinical Features, and Treatment Outcome // Arch Ophthalmol. 2003. Vol. 121, № 4. P. 491.
2. Mombaerts I. et al. Are Systemic Corticosteroids Useful in the Management of Orbital Pseudotumors? // Ophthalmology. American Academy of Ophthalmology, Inc. 1996. Vol. 103, № 3. P. 521-528.
3. Bartalena L. et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO // Eur J Endocrinol. 2008. Vol. 158, № 3. P. 273-285.
4. Birch-Hirschfeld A. Zur diagnostik und pathologie der orbital tumoren // Der Deutsch Ophthalmol Ges. 1905. Vol. 32. P. 127-135.
5. Lutt J. R. et al. Orbital Inflammatory Disease // Semin Arthritis Rheum. 2008. Vol. 37, № 4. P. 207-222.
6. Mombaerts I. et al. What is orbital pseudotumor? // Surv Ophthalmol. 1996. Vol. 41, № 1. P. 66-78.
7. Бровкина А. Ф. и др. Офтальмоонкология: руководство для врачей. М.: Медицина, 2002. 424 С.
8. Pakdaman M. N. Orbital inflammatory disease: Pictorial review and differential diagnosis // World J Radiol. 2014. Vol. 6, № 4. P. 106.
9. Chiu C. S., Rubin P. A. D. Pharmacotherapies and nonpharmacotherapies for orbital inflammatory disease // Int Ophthalmol Clin. 2004. Vol. 44, № 3. P. 165-185.
10. Espinoza G. M. Orbital inflammatory pseudotumors: Etiology, differential diagnosis, and management // Curr Rheumatol Rep. 2010. Vol. 12, № 6. P. 443-447.
11. Carruth B. P., Wladis E. J. Inflammatory modulators and biologic agents in the treatment of idiopathic orbital inflammation // Curr Opin Ophthalmol. 2012. Vol. 23, № 5. P. 420-426.
12. Char D. H., Miller T. Orbital Pseudotumor: Fine-needle Aspiration Biopsy and Response to Therapy // Ophthalmology. American Academy of Ophthalmology, Inc. 1993. Vol. 100, № 11. P. 1702-1710.
13. Shields J. A., Shields C. L., Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1 // Ophthalmology. 2004. Vol. 111, № 5. P. 997-1008.
14. Belanger C. et al. Inflammatory Disorders of the Orbit in Childhood: A Case Series // Am J Ophthalmol. 2010. Vol. 150, № 4. P. 460-463.
15. Gordon L. K. Orbital inflammatory disease: A diagnostic and therapeutic challenge // Eye. 2006. Vol. 20, № 10. P. 1196-1206.
16. Umehara H. et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 // Mod Rheumatol. 2012. Vol. 22, № 1. P. 21-30.
17. Sah R. P., Chari S. T. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis // Curr Opin Rheumatol. 2011. Vol. 23, № 1. P. 108-113.
18. Colombo F., Holbach L. M., Naumann G. O. H. Chronic inflammation in dermoid cysts: a clinicopathologic study of 115 patients // Orbit. 2000. Vol. 19, № 2. P. 97-107.
19. Goh A. S. et al. Orbital inflammation in a patient with extrascleral spread of choroidal malignant melanoma // Clin Exp Ophthalmol. 2001. Vol. 29, № 2. P. 97-99.
20. Foley M. R. et al. Orbital Inflammatory Syndromes with Systemic Involvement May Mimic Metastatic Disease // Ophthalmic Plast Reconstr Surg. 2003. Vol. 19, № 4. P. 324-327.
21. Bernardino C. R. et al. Angle-closure glaucoma in association with orbital pseudotumor // Ophthalmology. 2001. Vol. 108, № 9. P. 1603-1606.
22. Leone C. R., Lloyd W. C. Treatment Protocol for Orbital Inflammatory Disease // Ophthalmology. 1985. Vol. 92, № 10. P. 1325-1331.
23. Harris G. J. Idiopathic orbital inflammation: A pathogenetic construct and treatment strategy: The 2005 ASOPRS Foundation Lecture // Ophthal Plast Reconstr Surg. 2006. Vol. 22, № 2. P. 79-86.
24. I. Leibovitch et al. Intraorbital injection of triamcinolone acetonide in patients with idiopathic orbital inflammation: Commentary // Evidence-Based Ophthalmol. 2008. Vol. 9, № 3. P. 182-183.
25. Патент 2164140. РФ. Способ лечения псевдоопухолевых заболеваний орбиты: заявл. 28.12.1999, опубл. 20.03.2001 / Бровкина А. Ф. и др.
26. Гайсина Г. Ф. Оптимизация комплексной диагностики и консервативного лечения псевдотумора орбиты: автореф. дис.. .. к.м.н. Самара, 2008. 22 с.
27. Mazlumzadeh M. et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial // Arthritis Rheum. 2006. Vol. 54, № 10. P. 3310-3318.
28. Kahaly G. J. et al. Randomized, Single Blind Trial of Intravenous versus Oral Steroid Monotherapy in Graves’ Orbitopathy // J Clin Endocrinol Metab. 2005. Vol. 90, № 9. P. 5234-5240.
29. Bijlsma W. R., Paridaens D., Kalmann R. Treatment of severe idiopathic orbital inflammation with intravenous methylprednisolone // Br J Ophthalmol. 2011. Vol. 95, № 8. P. 1068-1071.
30. Rootman J. et al. Idiopathic Sclerosing Inflammation of the Orbit // Ophthalmology. 1994. Vol. 101, № 3. P. 570-584.
Review
For citations:
Levashov I.A., Yarovoy A.A. Idiopathic orbital disease and corticosteroids as first-line treatment: literature review. Lechaschi Vrach. 2020;(6):69-73. (In Russ.) https://doi.org/10.26295/OS.2020.64.89.013
Views:
332
JATS XML
Email this article 
